2012 ©
             Publication
Journal Publication
Title of Article Alteration of STK11 expression associated with cholangiocarcinoma progression 
Date of Acceptance 12 April 2023 
Journal
     Title of Journal In Vivo 
     Standard SCOPUS 
     Institute of Journal International Institute of Anticancer Research (IIAR) 
     ISBN/ISSN  
     Volume  
     Issue  
     Month
     Year of Publication 2023 
     Page  
     Abstract STK11 (serine/threonine kinase 11), a type of tumor suppressor controls AMPK signaling in a variety of cellular functions. STK11 gene mutations have been identified as a novel driver gene that promotes cancer progression. The purpose of this study was to investigate the alteration of STK11 and its correlation with clinicopathological data in cholangiocarcinoma (CCA). The results based on publicly available cancer datasets show that 2.7% of CCA cases had STK11 mutations. Most of STK11 gene mutations are a truncating type which result in low STK11 mRNA and protein expression. We detected a correlation between STK11 mutation status with the tendency of survival time of patients to be shorter. The results of qRT-PCR revealed that STK11 mRNA levels were statistically significantly lower in CCA patients with STK11 mutations compared to STK11 wild type (p-value = 0.013). Immunohistochemical staining showed high STK11 expression in 43.8% and low expression in 56.2% of CCA tissues examined. Low STK11 protein expression resulted in low prognosis compared with high STK11 expression, especially in CCA papillary carcinoma type. Univariate and multivariate analysis revealed that high STK11 expression was associated with a decreased hazard ratio of patient survival rates (HR = 0.696, p-value = 0.06 and HR = 0.666, p-value = 0.04, respectively). Our study demonstrated that alteration of STK11 mutational or mRNA/protein status might be used as a potential predictive biomarker for the prognosis of the clinical outcomes in CCA patients. 
     Keyword STK11, prognostic marker, predictive biomarker, cholangiocarcinoma 
Author
635090010-6 Miss PAPITCHAYA SIRITHAWAT [Main Author]
Associated Medical Sciences Master's Degree

Reviewing Status ไม่มีผู้ประเมินอิสระ 
Status ตีพิมพ์แล้ว 
Level of Publication นานาชาติ 
citation true 
Part of thesis true 
Attach file
Citation 0